Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Glioblastoma 5Gliosarcoma 4Squamous Cell Carcinoma of Head and Neck 3Glioma 3Brain Neoplasms 3Treatment-Refractory Solid Tumors 2Salivary Gland Neoplasms 2Central Nervous System Neoplasms 2Tongue Neoplasms 1Oligodendroglioma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1HPV-Negative Squamous Cell Carcinoma 1Esthesioneuroblastoma, Olfactory 1Ependymoma 1Carcinoma, Non-Small-Cell Lung 1Bites and Stings 1Astrocytoma 1Advanced Solid Tumors 1

Interventions

pembrolizumab 126Carboplatin 108Pemetrexed 76Paclitaxel 76Cisplatin 73Nivolumab 56Docetaxel 53Erlotinib Hydrochloride 50Gemcitabine 49Radiotherapy 48Bevacizumab 32osimertinib 31Cetuximab 29atezolizumab 25Cyclophosphamide 25durvalumab 24130-nm albumin-bound paclitaxel 22Oxaliplatin 19Fluorouracil 18Taxes 17Radiosurgery 17fludarabine 16Magnetic Resonance Spectroscopy 16Gefitinib 16Ipilimumab 15Vinorelbine 14Leucovorin 14Albumin-Bound Paclitaxel 14Vorinostat 13Radiation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoma, Non-Small-Cell Lung × Hydroxyurea × Clear all
NCT00002887 2013-09-17

Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡